醫渡科技(02158.HK):各業務板塊收入結構變得較平衡
醫渡科技(02158.HK)總裁兼首席財務官楊晶在電話會議中表示,集團大數據平臺和解決方案、生命科學解決方案、健康管理平臺和解決方案的收入佔比由5比2比3,變成各佔三分之一、較平衡的結構,大數據平臺和解決方案業務是集團經營時間最長和最重要的板塊,其每年擴展速度符合集團計劃,該業務未來會加大公共衛生服務的投資,將服務擴展至每年增加5至10間研究醫院,建設5至10間監管機構和區域平臺。
對於中央加強網絡信息保護,楊晶稱,集團起初已經非常重視數據安全保障,樂見個人信息保護法爲行業提供指引,而且法律不針對經過匿名處理的數據,集團會經過數據授權纔開展業務。
集團表示,國內每年藥物研發投入高過全球平均水平,推動整個生命科學解決方案行業高速發展,集團有能力滿足客戶需求,預計這個板塊會在未來3至5年持續增長。
截至今年9月底六個月,集團非國際財務報告準則經調整淨虧損由去年1.66億元擴大至3.21億元人民幣,集團表示,中期虧損擴大主要因爲員工數量增加,以維持技術和人才的優勢,導致營運費用上升,不過有信心未來營運費用下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.